147 related articles for article (PubMed ID: 6225289)
1. Therapeutical approach of hypercalcemia in malignancy.
Duprez D; Rottiers R; Vermeulen A
Acta Clin Belg; 1983; 38(3):165-70. PubMed ID: 6225289
[No Abstract] [Full Text] [Related]
2. [Therapeutic possibilities in paraneoplastic hypercalcemia].
Schürer CC; Peters U; Fischer JT
Med Welt; 1981 Aug; 32(32-33):1219-21. PubMed ID: 6456397
[No Abstract] [Full Text] [Related]
3. Drug therapy of hypercalcemia due to malignancy.
Raue F; Pecherstorfer M
Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
[No Abstract] [Full Text] [Related]
4. [Treatment of malignancy associated hypercalcemia].
Tai N; Inoue D
Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of tumor associated hypercalcemia].
Urologe A; 2004 Sep; 43(9):1185-6. PubMed ID: 15487037
[No Abstract] [Full Text] [Related]
6. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
Tai N; Inoue D
Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
[TBL] [Abstract][Full Text] [Related]
7. [Malignancy-associated hypercalcemia].
Oura S
Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of intravenous dichloromethylene diphosphonate in paraneoplastic hypercalcemia resistant to mithramycin].
Peyron R; Sereni D; Grateau G; Boissonnas A; Cremer GA; Laroche C
Rev Rhum Mal Osteoartic; 1984; 51(7-8):435-7. PubMed ID: 6238399
[No Abstract] [Full Text] [Related]
9. Salmon calcitonin is effective in combating hypercalcemia.
Silva OL; Becker KL
Geriatrics; 1973 Oct; 28(10):178 passim. PubMed ID: 4269646
[No Abstract] [Full Text] [Related]
10. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia of malignancy remains a clinically relevant problem.
Van Poznak C
Cancer J; 2006; 12(1):21-3. PubMed ID: 16613658
[No Abstract] [Full Text] [Related]
13. [Progress in therapy and diagnosis: Hypercalcemia due to parathyroid hormone-related protein producing neoplasms].
Tanaka Y; Okada Y
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):669-74. PubMed ID: 17506302
[No Abstract] [Full Text] [Related]
14. Hypercalcaemia. Management.
Selby PC; Peacock M; Marshall DH
Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
[No Abstract] [Full Text] [Related]
15. The treatment of hypercalcaemia of malignancy.
Heath D
Clin Endocrinol (Oxf); 1991 Feb; 34(2):155-7. PubMed ID: 2022066
[No Abstract] [Full Text] [Related]
16. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic hypercalcemia in gynecologic malignancy.
Holtz G
Obstet Gynecol Surv; 1980 Mar; 35(3):129-36. PubMed ID: 6987579
[No Abstract] [Full Text] [Related]
18. Hypercalcemia of malignancy: diagnosis and therapy.
Fetchick DA; Mundy GR
Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
[TBL] [Abstract][Full Text] [Related]
19. A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy.
Yates AJ; Murray RM; Jerums GJ; Martin TJ
Aust N Z J Med; 1987 Aug; 17(4):387-91. PubMed ID: 3435316
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
Raue F
Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
[No Abstract] [Full Text] [Related]
[Next] [New Search]